Cancer Research UK on Google+ Cancer Research UK on Facebook Cancer Research UK on Twitter

Osteoporosis risk and hormone therapy

Breast cancer treatment can affect your osteoporosis risk. There is information on this page about

 

Cancer treatment and osteoporosis risk

Osteoporosis is thinning of the bones so that they become more brittle. This gives an increased risk of fracture. As part of the natural ageing process our bones start to thin after the age of 35 or so, but this is not usually noticeable.

Any cancer treatment in women that lowers oestrogen levels can increase the risk of osteoporosis.

Treatments that lower oestrogen levels and may increase the risk of osteoporosis include

  • Chemotherapy that caused an early menopause
  • Hormone therapy with a drug called an LHRH analogue (eg Zoladex)
  • Hormone therapy with a drug called an aromatase inhibitor (such as anastrozole, exemestane or letrozole)
  • Radiotherapy to your ovaries to stop them working
  • Surgery to remove your ovaries when you were premenopausal

Tamoxifen for breast cancer usually only reduces bone density by a small amount. In postmenopausal women, aromatase inhibitors increase bone loss at an average rate of 1 to 3% per year. In young women who have had ovarian suppression followed by aromatase inhibitor therapy, bone density is lost at an average of 7 to 8% per year. Treatment with tamoxifen for 2 to 5 years before having aromatase inhibitors may slow down the rate of bone loss. 

Women who have had an early menopause (before the age of 45) due to cancer treatment or who have ovarian suppression therapy and aromatase inhibitors are at higher risk of bone loss.

If you are having breast cancer treatment it makes sense to discuss your possible risk of weaker bones with your cancer specialist. There are steps you can take to help keep your bones healthy.

Do also remember that your treatment may have these side effects. But it is also helping to control your cancer, or make sure it doesn’t come back, and that is very important for your health.

 

Who to talk to about your risk

You can talk to your doctor or nurse specialist if you are worried about bone thinning. UK guidelines recommend that women taking hormone therapy for breast cancer who are at high risk of osteoporosis should have their bone density measured before starting hormone therapy treatment. They should also have regular bone density checks during treatment. The test used is called a dual energy X-ray absorptiometry scan (DEXA scan) of bone mineral density (BMD).

 

Helping to prevent osteoporosis

There are several ways you can help to lower your osteoporosis risk

 

Calcium in your diet

An average adult should have about 700mg of calcium every day for good bone health. There is no evidence to suggest that women with breast cancer need any extra calcium. If you already have osteoporosis, more calcium may help – between 1,000 and 1,200mg a day.

Our main dietary source of calcium is dairy products. If you eat a normal, balanced diet including dairy foods, you are unlikely to be short of calcium. But some women with breast cancer don’t like to eat dairy foods. You get the most calcium from milk, cheese and yoghurt. But if you don’t eat dairy foods, there is also calcium in

  • Green vegetables, such as cabbage, broccoli and okra
  • Soya products, including tofu
  • Tinned fish where you eat the bones (sardines, salmon and pilchards)
  • Nuts
  • Dried fruit
  • Fortified breakfast cereals
  • Bread and other foods made from flour (all UK white flour is enriched with calcium and wholemeal flour contains it naturally)

There is calcium in tap water, but the amount varies depending on how hard the water is in your area. Some fruit juices and bottled waters have added calcium. Substitute milks, such as rice milk, oat milk and soya milk may also have added calcium. Check the label to find out how much they contain.

You could take supplements instead of calcium rich foods. Dieticians don’t recommend that you take more than the amount you should have in a normal diet. Too much calcium can be harmful. The Food Standards Agency says that taking up to 1,500mg a day is unlikely to do any harm.

For your body to use calcium, you also need vitamin D. Your body needs sun to make vitamin D. If you like being outside, then you probably get enough during the summer months to give you a vitamin D supply for a year. But if you are out in the sun, remember to protect against skin cancer with sunscreen. There is added vitamin D in margarine. It’s also found in oily fish and egg yolk.

You may want to ask your specialist or breast care nurse for a referral to a dietician at the hospital. A dietician can help you to work out whether you are getting enough calcium and vitamin D in your diet.

 

Exercise and bone health

Exercise is important for bone health. But it has to be weight bearing exercise. Swimming doesn’t help because your bones are not supporting your weight. If you already take part in sport, that’s great. But many of us don’t take enough regular exercise. The best way to start to tackle this is to try and bring exercise into your daily life. Walking is good. Household activities can also help, such as cleaning, gardening, shopping or even going up and down stairs. Or you could join an exercise group or class. It doesn’t have to be very energetic.

Gentle controlled exercise such as Tai Chi can be very good for you. Although swimming doesn’t help, exercise classes that you take at the swimming pool (aqua aerobics) can. Walking and exercising in the pool is quite hard work because of the resistance of the water. The most important thing is that you get into the habit of exercise, however you choose to do it.

If you’ve already got osteoporosis, or if there is any other reason why you need to take care, don’t jog or take exercise that involves jumping because it puts too much strain on your bones. Take advice from your doctor before starting any new exercise.

 

Bisphosphonate treatment for osteoporosis

Research trials have shown that drugs called bisphosphonates can prevent or slow bone loss in postmenopausal women taking aromatase inhibitor therapy. Your doctor will take into account your own bone density levels and risk of further loss of bone density when deciding whether you need to start bisphosphonate treatment. Women who have had an early menopause and are taking aromatase inhibitor therapy are most likely to benefit from bisphosphonates.

Bisphosphonates can maintain bone strength and may help to prevent breast cancer from spreading to the bones. Studies are looking at whether taking bisphosphonates can help women with breast cancer to live longer.

There are several different types of bisphosphonates, including

You have clodronate and ibandronate either as a tablet or by drip into your vein (infusion). You have zoledronic acid and pamidronate as a drip. You can find out more about having these drugs, and their particular side effects, by using the links above for each drug. You can also take a weekly bisphosphonate tablet for osteoporosis. This is called aledronate (Fosamax).

Bisphosphonates can cause side effects, such as an upset stomach and flu like symptoms. They can also affect the way your kidneys work.

 

More information about osteoporosis

The National Osteoporosis Society has a lot of information on the causes, prevention and treatment of osteoporosis. They also have guidelines for doctors treating women with hormone therapy for breast cancer. You can access the guidelines on the National Osteoporosis Society website.

Rate this page:
Submit rating

 

Rated 5 out of 5 based on 4 votes
Rate this page
Rate this page for no comments box
Please enter feedback to continue submitting
Send feedback
Question about cancer? Contact our information nurse team

No Error

Updated: 15 August 2014